LEADER 06680nam 22006852 450 001 9910459096203321 005 20151005020621.0 010 $a1-107-21867-5 010 $a0-511-85175-8 010 $a1-282-91852-4 010 $a9786612918520 010 $a0-511-91806-2 010 $a0-511-78086-9 010 $a0-511-91527-6 010 $a0-511-91904-2 010 $a0-511-91348-6 010 $a0-511-91708-2 035 $a(CKB)2670000000057925 035 $a(EBL)585303 035 $a(OCoLC)689996445 035 $a(SSID)ssj0000434099 035 $a(PQKBManifestationID)11300703 035 $a(PQKBTitleCode)TC0000434099 035 $a(PQKBWorkID)10396248 035 $a(PQKB)11546369 035 $a(UkCbUP)CR9780511780868 035 $a(MiAaPQ)EBC585303 035 $a(Au-PeEL)EBL585303 035 $a(CaPaEBR)ebr10433594 035 $a(CaONFJC)MIL291852 035 $a(EXLCZ)992670000000057925 100 $a20100519d2011|||| uy| 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCancer symptom science $emeasurement, mechanisms, and management /$fedited by Charles S. Cleeland, Michael J. Fisch [and] Adrian Dunn$b[electronic resource] 210 1$aCambridge :$cCambridge University Press,$d2011. 215 $a1 online resource (xvii, 356 pages) $cdigital, PDF file(s) 225 0 $aCambridge medicine Cancer symptom science 300 $aTitle from publisher's bibliographic system (viewed on 05 Oct 2015). 311 $a0-521-86901-3 320 $aIncludes bibliographical references and index. 327 $aMachine generated contents note: Preface; Foreword; Part I. Introduction: 1. Introduction to Cancer Symptom Science Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; 2. Researching the mechanisms underlying the symptoms of patients with cancer Adrian J. Dunn; 3. Cytokines, sickness behavior: a model for cancer symptoms Steven S. Zalcman, Randall T. Woodruff, Ruchika Mohla and Allan Siegal; Part II. Cancer Symptom Mechanisms and Models: Clinical and Basic Science: 4. The clinical science of cancer pain assessment and management Russell K. Portenoy and Victor T. Chang; 5. Pain: basic science: 5a. Mechanisms of disease-related pain in cancer: insights from the study of bone tumors Patrick W. Mantyh and Juan Miguel Jimenez Andrade; 5b. Neuropathic pain: basic science Patrick M. Dougherty and Haijun Zhang; 6. Cognitive dysfunction: is chemobrain real? Christina A. Meyers and Jeffrey S. Wefel; 7. Cognitive impairment: basic science Perry N. Fuchs, Jessica A. Boyette-Davis and Adrian J. Dunn; 8. Depression in cancer: pathophysiology at the mind-body interface Andrew H. Miller, Michael A. Burke and Charles L. Raison; 9. Depressive illness: basic science: 9a. Animal models of depressed mood and sickness behavior Adrian J. Dunn; 9b. From inflammation to sickness and depression: the cytokine connection Robert Dantzer and Keith W. Kelly; 10. Cancer-related fatigue: clinical science Xin Shelley Wang; 11. Developing translational animal models of cancer-related fatigue Mary W. Meagher; 12. Cancer anorexia/weight loss syndrome Aminah Jatoi and Nisha Lassi; 13. Appetite loss/cachexia: basic science Tristin D. Brisbois-Clarkson, Wendy V. Wismer and Vickie E. Baracos; 14. Sleep and its disorders: clinical science Sofia Ancoli-Israel and Lianqi Liu; 15. Sleep and its disorders Mark R. Opp and Luca Imeri; 16. Proteins and symptoms Bang-Ning Lee and James M. Reuben; 17. Genetic approaches to treating and preventing symptoms in patients with cancer Quiling Shi and Charles S. Cleeland; 18. Functional imaging of symptoms T. Dorina Papageorgiou, Edward F. Jackson and Javier O. Valenzuela; 19. High-dose therapy and posttransplantation symptom burden: striking a balance Sergio A. Giralt and Loretta A. Williams; Part III. Clinical Perspectives in Symptom Management and Research: 20. Promoting symptom research in cooperative groups Lynne I. Wagner and David Cella; 21. Practical aspects of symptom management in patients with cancer Richard T. Lee and Michael J. Fisch; Part IV. Symptom Measurement: 22. Symptom measurement by patient report Charles S. Cleeland and Tito R. Mendoza; 23. The economics of cancer-related symptoms: valuing supportive care interventions Lesley-Ann Miller and Jane C. Weeks; 24. Longitudinal models for symptoms Diane L. Fairclough; 25. Bayesian adaptive design: a new approach to test the effectiveness of symptom-reducing agents using patient-reported outcomes Valen E. Johnson and Tito R. Mendoza; Part V. Government and Industry Perspectives: 26. Promoting cancer symptom science research Ann O'Mara and Maria Sgambati; 27. Developing symptom management drugs Joanna M. Brell and Lori M. Minasian; 28. Cancer-related symptoms: issues for consideration in drug and therapeutic biological product label claims in the United States Jane A. Scott; 29. Symptom research: looking ahead Charles S. Cleeland, Adrian J. Dunn and Michael J. Fisch; Index. 330 $aCancer Symptom Science is the first interdisciplinary compilation of research on the mechanisms underlying the expression of cancer-related symptoms. It presents innovations in clinical, animal and in vitro research, research methods in brain imaging, and statistical-descriptive approaches to understanding the mechanistic basis of symptom expression. This volume also provides perspectives from patients, government and industry. By collecting and synthesizing the developing threads of new approaches to understanding cancer-related symptoms, the book promotes a pioneering framework for merging behavioral and biological disciplines to clarify mechanisms of symptom evolution, incorporating new technologies, testing novel agents for symptom control, and improving patient functioning and quality of life both during and after cancer treatment. With an expert editorial team led by Charles S. Cleeland, an internationally-recognized leader in cancer pain assessment and treatment, this is essential reading for surgical, clinical and medical oncologists, academic researchers, and pharmaceutical companies developing new agents to control symptom expression. 606 $aCancer$xPathophysiology 606 $aSymptoms 615 0$aCancer$xPathophysiology. 615 0$aSymptoms. 676 $a616.99/4071 702 $aCleeland$b Charles S. 702 $aFisch$b Michael J.$f1964- 702 $aDunn$b Adrian J. 801 0$bUkCbUP 801 1$bUkCbUP 906 $aBOOK 912 $a9910459096203321 996 $aCancer symptom science$91896991 997 $aUNINA LEADER 01944nam 2200637Ia 450 001 9910459330703321 005 20200520144314.0 010 $a1-282-42268-5 010 $a9786612422683 010 $a0-472-02239-3 024 7 $a10.3998/mpub.23627 035 $a(CKB)2670000000016517 035 $a(SSID)ssj0000344188 035 $a(PQKBManifestationID)11286438 035 $a(PQKBTitleCode)TC0000344188 035 $a(PQKBWorkID)10306791 035 $a(PQKB)11369744 035 $a(MiAaPQ)EBC3414514 035 $a(OCoLC)593239812 035 $a(MdBmJHUP)muse8440 035 $a(MiU)10.3998/mpub.23627 035 $a(Au-PeEL)EBL3414514 035 $a(CaPaEBR)ebr10326368 035 $a(CaONFJC)MIL242268 035 $a(OCoLC)824099847 035 $a(EXLCZ)992670000000016517 100 $a19941110d1995 ub 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aValue change in global perspective$b[electronic resource] /$fPaul R. Abramson and Ronald Inglehart 210 $aAnn Arbor $cUniversity of Michigan Press$dc1995 215 $axi, 180 p. $cill 300 $aBibliographic Level Mode of Issuance: Monograph 311 $a0-472-09591-9 311 $a0-472-06591-2 320 $aIncludes bibliographical references (p. 169-175) and index. 606 $aSocial surveys$zEurope 606 $aSocial values$zEurope 607 $aEurope$xSocial conditions$y20th century 608 $aElectronic books. 615 0$aSocial surveys 615 0$aSocial values 676 $a306/.094 700 $aAbramson$b Paul R$0543892 701 $aInglehart$b Ronald$0127386 712 02$aMichigan Publishing (University of Michigan) 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910459330703321 996 $aValue change in global perspective$92110684 997 $aUNINA